V1b receptors:: New probes for therapy

被引：6

作者：

Arban, Roberto ^{[1
]}

机构：

[1] Med Res Ctr, Psychiat Ctr Excellence Drug Discovery, GlaxoSmithKline Grp, Dept Biol, I-37135 Verona, Italy

来源：

ENDOCRINOLOGY | 2007年 / 148卷 / 09期

关键词：

D O I：

10.1210/en.2007-0735

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：4133 / 4135

页数：3

相关论文

共 25 条

[1]

Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation [J].

Aguilera, G ;

Rabadan-Diehl, C .

REGULATORY PEPTIDES, 2000, 96 (1-2) :23-29

[2]

Therapeutic potential of vasopressin receptor antagonists [J].

Ali, Farhan ;

Guglin, Maya ;

Vaitkevicius, Peter ;

Ghali, Jalal K. .

DRUGS, 2007, 67 (06) :847-858

[3]

Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4 [J].

Cheng, LL ;

Stoev, S ;

Manning, M ;

Derick, S ;

Pena, A ;

Ben Mimoun, M ;

Guillon, G .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (09) :2375-2388

[4]

[1-deamino-4-cyclohexylalanine] arginine vasopressin:: A potent and specific agonist for vasopressin V1b receptors [J].

Derick, S ;

Cheng, LL ;

Voirol, MJ ;

Stoev, S ;

Giacomini, M ;

Wo, NC ;

Szeto, HH ;

Mimoun, MB ;

Andres, M ;

Gaillard, RC ;

Guillon, G ;

Manning, M .

ENDOCRINOLOGY, 2002, 143 (12) :4655-4664

[5]

Pancreatic vasopressin V1b receptors:: characterization in In-R1-G9 cells and localization in human pancreas [J].

Folny, V ;

Raufaste, D ;

Lukovic, L ;

Pouzet, B ;

Rochard, P ;

Pascal, M ;

Serradeil-Le Gal, C .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (03) :E566-E576

[6]

Non-peptide vasopress in V1b receptor antagonists as potential drugs for the treatment of stress-related disorders [J].

Griebel, G ;

Stemmelin, J ;

Gal, CSL ;

Soubrié, P .

CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (12) :1549-1559

[7]

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders [J].

Griebel, G ;

Simiand, J ;

Gal, CSL ;

Wagnon, J ;

Pascal, M ;

Scatton, B ;

Maffrand, JP ;

Soubrié, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (09) :6370-6375

[8]

The Vasopressin V1b Receptor as a Therapeutic Target in Stress-related Disorders [J].

Griebel, Guy ;

Simiand, Jacques ;

Stemmelin, Jeanne ;

Serradeil-Le Gal, Claudine ;

Steinberg, Regis .

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (03) :191-200

[9]

Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors:: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist [J].

Griffante, C ;

Green, A ;

Curcuruto, O ;

Haslam, CP ;

Dickinson, BA ;

Arban, R .

BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (05) :744-751

[10]

Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: Anatomical support for its involvement in the central effects of vasopressin [J].

Hernando, F ;

Schoots, O ;

Lolait, SJ ;

Burbach, JPH .

ENDOCRINOLOGY, 2001, 142 (04) :1659-1668